发明名称 |
COMBINATION COMPRISING A SIGNAL TRANSDUCTION INHIBITOR AND AN EPOTHILONE DERIVATIVE |
摘要 |
The invention relates to a combination which comprises (a) a signal transduction inhibitor selected from a PDGF (platelet-derived growth factor) receptor tyrosine kinase inhibitor and an active ingredient which decreases the activity of the epidermal growth factor (EGF) an epothilone derivative o f formula (I) in which compound A represents O or NR n, wherein Rn is hydrogen or lower alkyl, R is hydrogen or lower alkyl, and Z is O or a bond, and optionally at least one pharmaceutically acceptable carrier for simultaneous , separate or sequential use, in particular, for the delay of progression or treatment of a proliferative disease; a pharmaceutical composition comprisin g such a combination; the use of such a combination for the preparation of a medicament for the delay of progression or treatment of a proliferative disease; a commercial package comprising such a combination as a combined preparation; and to a method of treatment of a warm-blooded animal.
|
申请公布号 |
CA2439268(C) |
申请公布日期 |
2010.01.19 |
申请号 |
CA20022439268 |
申请日期 |
2002.02.26 |
申请人 |
NOVARTIS AG |
发明人 |
BRANDT, RALF;BUCHDUNGER, ELISABETH;O'REILLY, TERENCE;ROTHERMEL, JOHN DAVID;PIETRAS, KRISTIAN;TRAXLER, PETER;WARTMANN, MARKUS;OESTMAN, ARNE;HELDIN, CARL-HENRIK |
分类号 |
A61K31/505;A61K45/00;A61K31/425;A61K31/427;A61K31/506;A61K31/519;A61K45/06;A61P35/00;A61P43/00 |
主分类号 |
A61K31/505 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|